Perelman School of Medicine/ Faculty Search/ Alix Eden Seif

Alix Eden Seif, MD, MPH

Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia

Department: Pediatrics

Contact information

Division of Oncology
Children's Hospital of Philadelphia
3501 Civic Center Blvd, CTRB 3004
Philadelphia, PA 19104

Office: 215-590-9996

Education:
BA (Linguistics - Honours, First Class)
McGill University, 1992.
MA (Linguistics)
McGill University, 1995.
MPH (Epidemiology and Biostatistics)
Oregon Health Sciences University, 2002.
MD
Oregon Health Sciences University, 2002.

Permanent link

Perelman School of Medicine > Faculty > Search

Selected Publications

Teachey DT, Rheingold SR, Maude SL, Zugmaier G, Barrett DM, Seif AE, Nichols KE, Suppa EK, Kalos M, Berg RA, Fitzgerald JC, Aplenc R, Gore L, and Grupp SA: Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine directed therapy. Blood Page: doi:10.1182/blood-2013-02-485623, 2013.

Walker DM, Fisher BT, Seif AE, Huang YSV, Torp K,Li Y, Aplenc R: Dexrazoxane Use in Pediatric Patients with Acute Lymphoblastic or Myeloid Leukemia From 1999 and 2009: Analysis of a National Cohort of Patients in the Pediatric Health Information Systems Database. Pediatric Blood & Cancer 60(4): 616-20, 2013.

Seif AE, Naranjo A, Baker DL, Bunin NJ, Kletzel M, Kretschmar CS, Maris JM, McGrady PW, von Allmen D, Cohn SL, London WB, Park JR, Diller LR, Grupp SA: ANBL00P1, A Children's Oncology Group Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma. Bone Marrow Transplantation 2013 Notes: doi: 10.1038/bmt.2012.276. [Epub ahead of print]

Kavcic M, Fisher BT*, Seif AE*, Li Y, Huang YS, Walker D, Aplenc R.: Leveraging Administrative Data to Monitor Rituximab Use in 2,875 Patients at 42 Free Standing Children’s Hospitals Across the United States. Journal of Pediatrics S0022-3476(12), 2013 Notes: In press. doi: 10.1016/j.jpeds.2012.11.038. *equal contribution.

Kavcic M, Fisher BT, Li Y, Seif AE, Torp K, Walker DM, Huang YS, Lee GE, Tasian SK, Vujkovic M, Bagatell R, Aplenc R.: Induction Mortality and Resource Utilization in Children Treated for Acute Myeloid Leukemia at Free-Standing Pediatric Hospitals in the United States. Cancer 2013 Notes: doi: 10.1002/cncr.27957. [Epub ahead of print]

Kavcic M, Fisher BT, Torp K, Li Y, Huang YS, Seif AE, Vujkovic M, Aplenc R: Assembly of a Cohort of Children Treated for Acute Myeloid Leukemia at Free-standing Children’s Hospitals in the United States using an Administrative Database Pediatric Blood & Cancer 60(3): 508-11, 2013.

Fisher BT, Singh S, Huang YSV, Li Y, Gregory J, Walker D, Seif AE, Kavcic M, Aplenc R: Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009. Pediatric Blood & Cancer 2013 Notes: in press.

Lothstein K, Fisher BT, Li Y, Seif A, Harris T, Torp K, Kavcic M, Huang YSV, Rheingold SR, Aplenc R.: Zoonotic Infections in Pediatric Patients with Acute Leukemia. Pediatric Blood & Cancer 2013 Notes: in press.

Fisher BT, Harris T, Torp K, Seif AE, Shah A, Huang Y-SV, Bailey LC, Kersun LS, Reilly AF, Rheingold SR, Walker D, Li Y, Aplenc R: Establishment of an 11-Year Cohort of 8733 Pediatric Patients Hospitalized at United States Free-standing Children’s Hospitals with de novo Acute Lymphoblastic Leukemia from Healthcare Administrative Data Medical Care epub, March 2012.

Fisher BT, Gerber JS, Leckerman K, Seif AE, Huang YS, Li Y, Harris T, Torp K, Rheam D, Shah A, Walker D, Aplenc R.: Variation in Hospital Antibiotic Prescribing Practices for Children with Acute Lymphoblastic Leukemia. Leukemia and Lymphoma 2012 Notes: epub ahead of print.